Opus Point Partners’ AUM, History and Investments

1. Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. (NYSE:MRK) is represented in Opus Point Partners’ equity portfolio by a $5.36 million position that contains 83,700 shares as of the end of June, unchanged over the quarter. Other investors with more substantial stakes in Merck & Co., Inc. (NYSE:MRK) include billionaire Ken Fisher’s Fisher Asset Management, and Samuel Isaly’s OrbiMed Advisors, which hold 7.10 million shares and 6.28 million shares, respectively.

For the second quarter, Merck & Co., Inc. (NYSE:MRK) posted revenue of $9.93 billion, which topped the consensus estimate by $180.0 million, while EPS of $1.01 was higher than the expected $0.87. The company also updated its full-year guidance and currently expects revenue between $39.40 billion and $40.40 billion and EPS in the range of $3.76 to $3.88.